Hypertension, insulin resistance and vitric oxide bioavailability

Hypertension, insulin resistance and vitric oxide bioavailability

Bibliographic Details
Main Author:	Mohteshamzadeh, Mobin
Published:	University of Newcastle upon Tyne 2002
Subjects:	616 Cardiovascular risk
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.270768

Similar Items

Câteva descoperiri vitrice din Dobrogea romană
by: Sever-Petru BOȚAN, et al.
Published: (2020-11-01)

The Occurrence of Vitric Tuff in Quaternary Deposits of Gljev in Dalmatia (Southern Croatia)
by: Ante Šušnjara, et al.
Published: (2010-11-01)

Beta-amyloid/plasma lipoprotein interactions : implications for vascular damage
by: Stanyer, Lee
Published: (2002)

Pulmonary and renal vitric oxide metabolism following infrarenal aortic cross-clamp induced ischaemia-reperfusion injury
by: Pararajasingam, Ravi
Published: (2000)

IS THE TOTAL CARDIOVASCULAR RISK OF HYPERTENSIVE PATIENTS HIGHER THAN THE AMOUNT OF INDIVIDUAL RISKS OF THE INVOLVED FACTORS?
by: Gabriel Cristian Bejan, et al.
Published: (2019-03-01)

Insulin resistance and cardiovascular risk in older adult Nigerians with type 2 diabetes
by: Ifeoma Christiana Udenze, et al.
Published: (2019-01-01)

Prognostic value of risk factors for cardiovascular diseases and target organ damages for the occurrence of resistant hypertension
by: A Yu Lazutkina, et al.
Published: (2015-04-01)

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
by: Kwang-il Kim, et al.
Published: (2019-08-01)

The relationship between serum thyroid-stimulating hormone, insulin resistance, and cardiovascular risk factors in obese patients with subclinical hypothyroidism
by: N.V. Pasiechko, et al.
Published: (2020-11-01)

Insulin action and hypertension : the effect of hyperaldosteronism and its treatment
by: McMurray, E. M.
Published: (2012)

Productividad de lechuga Lactuca sativa en condiciones de macrotúnel en suelo Vitric haplustands
by: Pedro Velásquez, et al.
Published: (2014-12-01)

Resistant hypertension in elderly patient with nephropathy in primary and secondary care settings
by: Valerio Massimo Magro, et al.
Published: (2016-11-01)

ANALISYS OF RISK FACTORS IN HYPERTENSIVE PATIENTS IN BRANIK
by: Matjaž Klemenc
Published: (2001-11-01)

Psoriasis Severity—A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome
by: Melita Vuksic Polic, et al.
Published: (2018-07-01)

Statins in arterial hypertension treatment
by: O. N. Tkacheva, et al.
Published: (1970-01-01)

The importance of cardiovascular risk factors in approaching the hypertensive patient by the family doctor
by: Cristina-Gabriela MILITARU, et al.
Published: (2021-06-01)

INDIVIDUAL, ABSOLUTE AND RELATIVE CARDIOVASCULAR RISK IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION AND ITS DYNAMICS UNDER ANTIHYPERTENSIVE TREATMENT
by: B. A. Hapayev, et al.
Published: (2001-06-01)

Dietary sucrose, insulin resistance and the heart
by: Winter, Stephen A.
Published: (1995)

Prevalence and determinants of Systemic Hypertension in Inhabitants of high altitude of Nepal
by: Dipanker Prajapati
Published: (2020-05-01)

Application of Bokashi Botom Ash for Increasing Upland Rice Yield and Decreasing Grain Pb Content in Vitric Hapludans
by: Nunung Sondari, et al.
Published: (2012-05-01)

Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a)
by: Lyudmila Korostovtseva, et al.
Published: (2020-06-01)

Orthostatic hypertension in cardiovascular risk stratification in hypertensive patients
by: E. Yu. Gubareva, et al.
Published: (2021-04-01)

Insulin resistance : the effect of diet and autoimmunity
by: Bradley, Una Marie
Published: (2010)

Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population[S]
by: Lin Ding, et al.
Published: (2015-04-01)

Pre-hypertension and cardiovascular risk in young men from the Far East Military Region
by: S. L. Zharsky, et al.
Published: (2009-06-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Should a statin be given to all hypertensive patients?
by: Harry Struijker-Boudier
Published: (2017-04-01)

Arterial fibrillation and heart failure
by: Khand, Aleem U.
Published: (2001)

LIPITENSION : Interplay between dyslipidemia and hypertension
by: Jamshed J Dalal, et al.
Published: (2012-01-01)

Endothelial dysfunction in hypertension: cause or effect?
by: A. Yu. Gorshkov, et al.
Published: (2019-12-01)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
by: Hae-Young Lee, et al.
Published: (2019-08-01)

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION
by: E. Yu. Gubareva, et al.
Published: (2018-05-01)

Comprehensive assessment of cardiovascular risk factors of arterial hypertension in indigenous and non-indigenous inhabitants of Mountain Shoria
by: T A Mulerova, et al.
Published: (2017-03-01)

Comprehensive assessment of cardiovascular risk factors of arterial hypertension in indigenous and non-indigenous inhabitants of Mountain Shoria
by: Mulerova T.A., et al.
Published: (2017-02-01)

Modelling methodologies to assess insulin resistance and insulin secretion in type 2 diabetes subjects
by: Agbaje, Olorunsola Fatai
Published: (2003)

Mechanisms of insulin resistance in prenatally programmed rats
by: Cleasby, Mark E.
Published: (2002)

Biochemical and genetic studies of human insulin resistance
by: Humphreys, P.
Published: (1996)

Studies in body composition, insulin resistance and exercise
by: Khoo, Eric Yin Hao
Published: (2011)

Determinants and consequences of insulin resistance in human disease
by: Au, S. T. B.
Published: (2008)

Dietary effects on insulin resistance and vascular risk
by: Spence, M.
Published: (2006)